Dare Bioscience | 10-Q: Quarterly report
Dare Bioscience | 8-K: Daré Bioscience Reports First Quarter 2024 Financial Results and Provides Company Update Conference Call and Webcast Today at 4:30 p.m. ET Development Program Highlights and Anticipated 2024 Milestones
Dare Bioscience | EFFECT: Others
Dare Bioscience | 424B5: Prospectus
Dare Bioscience | EFFECT: Others
Dare Bioscience | 424B3: Prospectus
Dare Bioscience | 8-K: Current report
Dare Bioscience | ARS: Annual Report to Security Holders
Dare Bioscience | DEFA14A: Others
Dare Bioscience | DEF 14A: Definitive information statements
Dare Bioscience | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Dare Bioscience | S-3: Registration statement for specified transactions by certain issuers
Dare Bioscience | S-3: Registration statement for specified transactions by certain issuers
Dare Bioscience | 424B5: Prospectus
Dare Bioscience | 10-K: Annual report
Dare Bioscience | 8-K: Current report
Dare Bioscience | 4: Statement of changes in beneficial ownership of securities-Officer Fair John A
Dare Bioscience | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON SABRINA MARTUCCI
Dare Bioscience | 4: Statement of changes in beneficial ownership of securities-Officer Haring-Layton MarDee
Dare Bioscience | 3: Initial statement of beneficial ownership of securities-Officer Haring-Layton MarDee
No Data